KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Change in Accured Expenses (2016 - 2026)

Amgen has reported Change in Accured Expenses over the past 18 years, most recently at -$75.0 million for Q1 2026.

  • For Q1 2026, Change in Accured Expenses rose 3.85% year-over-year to -$75.0 million; the TTM value through Mar 2026 reached -$153.0 million, down 318.57%, while the annual FY2025 figure was -$156.0 million, 269.57% down from the prior year.
  • Change in Accured Expenses for Q1 2026 was -$75.0 million at Amgen, down from $94.0 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $1.1 billion in Q4 2023 and troughed at -$501.0 million in Q3 2023.
  • A 5-year average of $53.6 million and a median of -$75.0 million in 2026 define the central range for Change in Accured Expenses.
  • On a YoY basis, Change in Accured Expenses climbed as much as 401.37% in 2023 and fell as far as 219.57% in 2023.
  • Year by year, Change in Accured Expenses stood at -$366.0 million in 2022, then soared by 401.37% to $1.1 billion in 2023, then plummeted by 34.0% to $728.0 million in 2024, then crashed by 87.09% to $94.0 million in 2025, then plummeted by 179.79% to -$75.0 million in 2026.
  • Business Quant data shows Change in Accured Expenses for AMGN at -$75.0 million in Q1 2026, $94.0 million in Q4 2025, and -$180.0 million in Q3 2025.